In 137 LC cases in advanced stages (III/IV) treated with platinum-gemcitabine, Joerger et al. analyzed the association between 23 polymorphisms and survival and reported an association between ERCC1 rs11615 polymorphism (T allele) and shorter survival, when compared to patients with the C/C genotype29. The gene discussed is ERCC1; the disease is laryngotracheoesophageal cleft.